The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wilson Mark Andrew since 2020.
This trader's CIK number is 1808356.
At the time of last reporting, Wilson Mark Andrew was the Chief Legal Officer of Nektar Therapeutics. (stock ticker symbol NKTR).
Also see all insider trading activities at Nektar Therapeutics.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | NKTR | 0 | $0 | 21,712 | $35,821 | 0 | $0 |
| 2024 | NKTR | 0 | $0 | 25,924 | $29,831 | 0 | $0 |
| 2023 | NKTR | 0 | $0 | 30,218 | $39,404 | 0 | $0 |
| 2022 | NKTR | 0 | $0 | 18,676 | $98,676 | 0 | $0 |
| 2021 | NKTR | 0 | $0 | 17,908 | $300,428 | 5,344 | $47,027 |
| 2020 | NKTR | 0 | $0 | 4,597 | $90,547 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-19 | NKTR | Sale | 676 | 26.59 | 17,974 |
| 2025-05-19 | NKTR | Sale | 9,996 | .67 | 6,697 |
| 2025-02-19 | NKTR | Sale | 11,040 | 1.01 | 11,150 |
| 2024-11-19 | NKTR | Sale | 6,407 | 1.01 | 6,471 |
| 2024-08-19 | NKTR | Sale | 5,651 | 1.28 | 7,233 |
| 2024-05-17 | NKTR | Sale | 6,260 | 1.75 | 10,955 |
| 2024-02-20 | NKTR | Sale | 7,606 | .68 | 5,172 |
| 2023-11-17 | NKTR | Sale | 7,179 | .49 | 3,517 |
| 2023-08-16 | NKTR | Sale | 7,221 | .78 | 5,632 |
| 2023-05-16 | NKTR | Sale | 7,543 | .72 | 5,430 |
| 2023-02-16 | NKTR | Sale | 8,275 | 3.00 | 24,825 |
| 2022-11-16 | NKTR | Sale | 8,690 | 3.57 | 31,023 |
| 2022-08-16 | NKTR | Sale | 3,189 | 4.76 | 15,179 |
| 2022-05-16 | NKTR | Sale | 3,136 | 3.95 | 12,387 |
| 2022-02-16 | NKTR | Sale | 3,661 | 10.95 | 40,087 |
| 2021-11-16 | NKTR | Sale | 6,564 | 13.16 | 86,382 |
| 2021-08-16 | NKTR | Sale | 1,910 | 13.83 | 26,415 |
| 2021-05-17 | NKTR | Sale | 1,917 | 18.30 | 35,081 |
| 2021-02-16 | NKTR | Sale | 2,173 | 22.37 | 48,610 |
| 2021-02-03 | NKTR | Sale | 5,344 | 19.45 | 103,940 |
| 2021-02-03 | NKTR | Option Ex | 5,344 | 8.80 | 47,027 |
| 2020-11-16 | NKTR | Sale | 1,539 | 16.93 | 26,055 |
| 2020-08-17 | NKTR | Sale | 1,529 | 19.67 | 30,075 |
| 2020-05-18 | NKTR | Sale | 1,529 | 22.51 | 34,417 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wilson Mark Andrew (Chief Legal Officer of Nektar Therapeutics at the time of this reporting) see the Securities and Exchange Commission (SEC) website.